Journal Finder

Food Additives & Contaminants: Part B publishes surveillance data indicating the presence and levels of occurrence of designated food additives, residues and contaminants in foods and animal feed. Data using validated methods must meet stipulated quality standards to be acceptable and must be presented in a prescribed format for subsequent data-handling. Food Additives & Contaminants: Part B has a restricted scope in terms of classes of food additives, residues and contaminants that are included, being based on a goal of covering those areas where there is a need to record surveillance data for the purposes of exposure and risk assessment. The scope is initially restricted to: 1. Additives - food colours, artificial sweeteners, and preservatives; 2. Residues - veterinary drug and pesticide residues; 3. Contaminants - metals, mycotoxins, phycotoxins, plant toxins, nitrate/nitrite, PCDDs/PCFDs, PCBs, PAHs, acrylamide, 3-MPCD and contaminants derived from food packaging. Papers reporting surveillance data in areas other than the above should be submitted to Part A. The scope of Part B will be expanded from time-to-time to ensure inclusion of new areas of concern. Readership The readership includes scientists involved in all aspects of food safety and quality and particularly those involved in monitoring human exposure to chemicals from the diet. Disclaimer for Scientific, Technical and Social Science Publications Taylor & Francis make every effort to ensure the accuracy of all the information (the 'Content') contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

Food and Agricultural Immunology presents original immunological research with food, agricultural, environmental and veterinary applications. The primary focus of the journal is on the use of immunological techniques and methods which have food, agricultural or veterinary applications. The journal has a wide remit within its chosen subject and welcomes papers directed towards an understanding of the interactions at the interface of the food and immune systems including studies on: * Development of diagnostic systems - all types of ligand based assays, e.g. antibody, aptmer; * Application of ligand based assays to the detection or identification of molecules of interest in Food Science, Agricultural Research, Veterinary Investigations and Clinical Systems relating to Food Allergy or Sensitivity to Agricultural Chemicals; * Studies on allergy and allergic reactions: * Development of allergen-free food systems; * Development of novel assay formats; * Applications of assay systems to the monitoring of food items in relation to safety and labelling; * Food Quality issues, e.g. speciation, adulteration and contamination. Disclaimer for Scientific, Technical and Social Science Publications Taylor & Francis make every effort to ensure the accuracy of all the information (the 'Content') contained in its publications. However, Taylor & Francis and its agents and licensors make no representations or warranties whatsoever as to the accuracy, completeness or suitability for any purpose of the Content and disclaim all such representations and warranties whether express or implied to the maximum extent permitted by law. Any views expressed in this publication are the views of the authors and are not the views of Taylor & Francis.

For a journal statement regarding "Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize", published in Food and Chemical Toxicology, Volume 50, Issue 11, November 2012, Pages 4221-4231, please click here.Food and Chemical Toxicology (FCT), an internationally renowned journal, aspires to publish original research articles and reviews on toxic effects, in animals or humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs, and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products, and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques, particularly those fostering the 3 Rs.The principal aim of the journal is to publish high impact, scholarly work and to serve as a multidisciplinary forum for research in toxicology. Papers submitted will be judged on the basis of scientific originality and contribution to the field, quality and subject matter. Studies should address at least one of the following:Physiological, biochemical, or pathological changes induced by specific substancesTechniques for assessing potential toxicity, including molecular biologyMechanisms underlying toxic phenomenaToxicological examinations of specific chemicals or consumer products, both those showing adverse effects and those demonstrating safety, that meet current standards of scientific acceptabilityManuscripts concerning materials/substances of only local interest for which the chemical composition of the material/substance is not clearly defined will not be considered. Manuscripts addressing only pharmacological properties, or only potentially beneficial effects using in in vitro or in vivo systems, are not within the scope of the journal.FCT is committed to the highest standards. Only papers that have not been previously published, that fit in the above mentioned scope, and that have been reviewed by experts in the field prior to publication will be accepted. Cover letters must state that the paper is new and original and not under consideration for publication elsewhere. Papers pending in other journals will not be considered. Co-authors should be individuals who have contributed substantially to the content of the papers.Benefits to authorsWe provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see the Guide for Authors for information on article submission. If you require further information or help, please visit our support pages: http://support.elsevier.com

The journal Forensic Toxicology provides an international forum for publication of studies on toxic substances, drugs of abuse, doping agents, chemical warfare agents, and their metabolisms and analyses, which are related to laws and ethics. It includes original articles, reviews, mini-reviews, short communications, and case reports. Although a major focus of the journal is on the development or improvement of analytical methods for the above-mentioned chemicals in human matrices, appropriate studies with animal experiments are also published.Forensic Toxicology is the official publication of the Japanese Association of Forensic Toxicology (JAFT) and is the continuation of the Japanese Journal of Forensic Toxicology (ISSN 0915-9606).This publication is supported in part by a Grant-in-Aid for Publication of Scientific Research Results from the Japan Society for the Promotion of Science.

Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including:

Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a monthly point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research, from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.

Green Chemistry provides a unique forum for the publication of innovative research on the development of alternative green and sustainable technologies. Based on the, but not limited to, the twelve principles of green chemistry defined by Anastas and Warner (Green Chemistry: Theory and Practice, P T Anastas and J C Warner, Oxford University Press, Oxford, 1998). Green chemistry is, by definition, a continuously-evolving frontier. Therefore, the inclusion of a particular material or technology does not, of itself, guarantee that a paper is suitable for the journal. To be suitable, the novel advance should have the potential for reduced environmental impact relative to the state of the art. Green Chemistry does not normally deal with research associated with 'end-of-pipe' or remediation issues.

Aims and Scope Download Flyer Founded by the Swiss Chemical Society in 1917.Helvetica Chimica Actais a monthly multidisciplinary journal dedicated to the dissemination of knowledge in all areas of chemistry and to the timely publication of original full-paper contributions from all over the world. With emphasis on the multidisciplinary nature of the journal. progress in subdisciplines including but not limited to organic. inorganic. physical. technical. and analytical chemistry is reported. Outstanding professionals referee all contributions. and papers are published. on average. within 3 months of receipt. The journal publishes more than 250 papers per year. and each monthly issue contains an average of more than 200 pages. There is no restriction on the length of the papers or the scope of the chemistry presented. Preliminary communications and review papers are considered as well. If you would like to receive an e-mail as soon as a new issue has been published. simply click on “Get New Content Alerts” above. Registration is easy. fast and free. Volume 94. 12 Issues in 2011. How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'Helv. Chim.

C. elegans RDE-4 is a double-stranded RNA binding protein that has been shown to play a key role in response to foreign double-stranded RNA (dsRNA). We have used diverse tools for analysis of gene function to characterize the domain and organismal foci of RDE-4 action in C. elegans. First, we examined the focus of activity within the RDE-4 protein, by testing a series of RDE-4 deletion constructs for their ability to support dsRNA-triggered gene silencing. These assays indicated a molecular requirement for a linker region and the second dsRNA-binding domain of RDE-4, with ancillary contributions to function from the C and N terminal domains. Second, we used mosaic... continue reading.

Unofficial 2009 Impact Factor: 1.754**The Unofficial 2009 Impact Factor for Human & Experimental Toxicology has been calculated by dividing the number of times original papers, reviews and other citeable items published in 2008 were cited in 2009, by the number of such articles published in 2008 (based on SCOPUS data).

The IEEE Transactions on NanoBioscience reports on original, innovative, and interdisciplinary research, both fundamental and applied, focusing on nano- to micro-scale biological systems. The journal invites contributions describing advances in bio-science, -technology, and -engineering, from biomolecular to multi-cellular domains, concerning their physics (e.g., mechanics, materials, electromagnetism); their chemistry (e.g., DNA, proteins, biochemical pathways); or their information storage and processing (e.g., biological signals, algorithms, and computation).

Indexed in Pubmed® and Medline®, products of the United States National Laboratory of Medicine
   

he journal Immunopharmacology and Immunotoxicology is devoted to preclinical and clinical studies about the regulatory effects of various agents on immunocompetent cells as well as the immunotoxicity exerted by xenobiotics and drugs. On these bases, the journal encompasses a broad range of pathologies (e.g., acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation and primary and secondary immunodeficiencies).In this framework, the journal will cover new emerging areas of science of broad interest, such as agricultural biotechnology; atherosclerosis; cytokine and growth factor regulation; dendritic cell therapy; food immunology and safety; forensic immunopathology; innate immunity regulation; microbial immunomodulators; mucosal immunity; drug development; psychoneuroimmunology; stem cell therapy; veterinary immunopathology; and vaccines. While articles related to purified extracts may be considered, research on crude botanical extracts are discouraged.Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, invited reviews, and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).Read More: http://informahealthcare.com/page/ipi/Description.

The aim of the International Institute of Anticancer Research (IIAR) is to provide an independent platform for international cooperation in the fight against cancer. The IIAR will advance, protect and support throughout the world the ideals of freedom, peace, health, scientific knowledge, equality, welfare and mutual respect among communities in science and life.This site provides information on the aims and activities of the IIAR, including current cancer research projects and invitations for cooperation.The IIAR is supported by the three international peer-reviewed journals ANTICANCER RESEARCH, IN VIVO and CANCER GENOMICS & PROTEOMICS which are also available online through the Stanford University HighWire Press.